Indefinite Delivery Contract SPE2DB20D9354

This is a $499,999,999 Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities nationwide.

Under this IDC, DMS Pharmaceutical Group has been awarded multiple delivery orders for specialized pharmaceutical products such as Botox, Xolair, Trikafta, Jakafi, Xtandi, and others. These delivery orders, which do not have set-aside designations, leverage DMS Pharmaceutical Group's status as a woman-owned small business to secure direct federal awards across various medical product categories. The contracts cover a wide range of pharmaceutical items required to support the recurring medical supply needs of the Department of Defense healthcare system, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.